Skip to main content
Top
Published in: European Journal of Pediatrics 9/2003

01-09-2003 | Original Paper

The burden of acute otitis media on the patient and the family

Authors: David Greenberg, Natasha Bilenko, Zvika Liss, Tomer Shagan, Orly Zamir, Ron Dagan

Published in: European Journal of Pediatrics | Issue 9/2003

Login to get access

Abstract

The aim of our study was to determine the burden of acute otitis media (AOM) on patients and their families. Parents of children with AOM were interviewed with regard to the week preceding the AOM diagnosis and every 3 days henceforth for an additional 21 days. The interview included information on loss of workdays, use of health care services and impact on the patient's and family's quality of life. Parents of age- and neighbourhood-matched controls were interviewed in an identical manner. A total of 150 patients and 51 controls were included in the analysis. The following variables differed significantly ( P <0.001) between patients and controls (mean ± SD): non-routine days 18.5±11.0 in patients versus 3.4±6.5 in controls; number of visits to primary health centres 2.6±1.6 versus 0.4±0.6; number of emergency room visits 0.2±0.5 versus 0.1±0.02 and number of visits to an otolaryngology clinic 0.3±0.6 versus 0. Days of antibiotic and over the counter drug use were 9.0±5.6 versus 0.3± 0.9 and 7.0±6.0 versus 4.9±6.0, respectively per episode. The mean loss of workdays per child was 1.6±1.8 in patients versus 0.25±0.6 in controls, for working mothers and 0.6±1.1 versus 0.1±0.4 for working fathers; duration of absenteeism from day care facilities was 3.5±2.5 versus 0.9±2.7. Conclusion: Acute otitis media significantly reduces the quality of life of both child and parents, causes substantial use of medical services and significant loss of workdays.
Literature
1.
go back to reference Alsarraf R, Jung CJ, Perkins J, Crowley C, Alsarraf NW, Gates GA (1999) Measuring the indirect and direct costs of acute otitis media. Arch Otolaryngol Head Neck Surg 125: 12–18PubMed Alsarraf R, Jung CJ, Perkins J, Crowley C, Alsarraf NW, Gates GA (1999) Measuring the indirect and direct costs of acute otitis media. Arch Otolaryngol Head Neck Surg 125: 12–18PubMed
3.
go back to reference Capra AM, Lieu TA, Black SB, Shinefield HR, Martin KE, Klein JO (2000) Costs of otitis media in a managed care population. Pediatr Infect Dis J 19: 354–355CrossRefPubMed Capra AM, Lieu TA, Black SB, Shinefield HR, Martin KE, Klein JO (2000) Costs of otitis media in a managed care population. Pediatr Infect Dis J 19: 354–355CrossRefPubMed
4.
go back to reference Carabin H, Gyorkos TW, Soto JC, Penrod J, Joseph L, Collet JP (1999) Estimation of direct and indirect costs because of common infections in toddlers attending day care centers. Pediatrics 103: 556–564PubMed Carabin H, Gyorkos TW, Soto JC, Penrod J, Joseph L, Collet JP (1999) Estimation of direct and indirect costs because of common infections in toddlers attending day care centers. Pediatrics 103: 556–564PubMed
5.
go back to reference Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344: 403–409PubMed Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344: 403–409PubMed
6.
go back to reference Gates GA (1996) Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg 11: 525–530 Gates GA (1996) Cost-effectiveness considerations in otitis media treatment. Otolaryngol Head Neck Surg 11: 525–530
7.
go back to reference Huse DM, Meissner HC, Lacey MJ, Oster G (1994) Childhood vaccination against chickenpox: an analysis of benefits and costs. J Pediatr 124: 869–874PubMed Huse DM, Meissner HC, Lacey MJ, Oster G (1994) Childhood vaccination against chickenpox: an analysis of benefits and costs. J Pediatr 124: 869–874PubMed
8.
go back to reference Jacobs MR (2002) Prevention of otitis media: role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance J Pediatr 141: 287–293 Jacobs MR (2002) Prevention of otitis media: role of pneumococcal conjugate vaccines in reducing incidence and antibiotic resistance J Pediatr 141: 287–293
9.
go back to reference Kaplan B, Wandstrat TL, Cunningham JR (1997) Overall cost in the treatment of otitis media. Pediatr Infect Dis J 16: S9–S11CrossRefPubMed Kaplan B, Wandstrat TL, Cunningham JR (1997) Overall cost in the treatment of otitis media. Pediatr Infect Dis J 16: S9–S11CrossRefPubMed
10.
go back to reference Klein JO (1993) Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 12: 973–975PubMed Klein JO (1993) Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 12: 973–975PubMed
11.
go back to reference Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, Miller MA, Shinefield HR (2000) Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 283: 1460–1468PubMed Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, Miller MA, Shinefield HR (2000) Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. JAMA 283: 1460–1468PubMed
12.
go back to reference Managed Care Advisory Panel (1999) Streptocococcus pneumoniae conjugate vaccine managed care advisory panel recommendations on Pnc7 and vaccine reimbursement guidelines. Am J Manag Care 5: S976–S980 Managed Care Advisory Panel (1999) Streptocococcus pneumoniae conjugate vaccine managed care advisory panel recommendations on Pnc7 and vaccine reimbursement guidelines. Am J Manag Care 5: S976–S980
13.
go back to reference Mortality and Morbidity Weekly Report (1997) Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices. MMRW 46 (RR-8): 1–24 Mortality and Morbidity Weekly Report (1997) Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices. MMRW 46 (RR-8): 1–24
14.
go back to reference Niemela M, Uhari M, Mottonen M, Pokka T (1999) Costs arising from otitis media. Acta Paediatr 88: 553–556CrossRefPubMed Niemela M, Uhari M, Mottonen M, Pokka T (1999) Costs arising from otitis media. Acta Paediatr 88: 553–556CrossRefPubMed
15.
go back to reference Nurmi T, Salminen E, Ponka A (1991) Infections and other illnesses of children in day-care centers in Helsinki. II. The economic losses. Infection 19: 331–335PubMed Nurmi T, Salminen E, Ponka A (1991) Infections and other illnesses of children in day-care centers in Helsinki. II. The economic losses. Infection 19: 331–335PubMed
16.
go back to reference Weycker D, Richardson E, Oster G (2000) Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs. Am J Manag Care 6: S526–S535PubMed Weycker D, Richardson E, Oster G (2000) Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs. Am J Manag Care 6: S526–S535PubMed
Metadata
Title
The burden of acute otitis media on the patient and the family
Authors
David Greenberg
Natasha Bilenko
Zvika Liss
Tomer Shagan
Orly Zamir
Ron Dagan
Publication date
01-09-2003
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 9/2003
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-003-1260-5

Other articles of this Issue 9/2003

European Journal of Pediatrics 9/2003 Go to the issue